Navigation Links
Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Date:9/11/2007

a from a cardiovascular outcomes trial in its label.

Given the strength and consistency of the ACTOS data as demonstrated by the prospective studies, meta-analysis, and observational studies, Takeda remains confident in the ACTOS safety profile regarding the risk of macrovascular ischemic events.

About the PROactive Study

The PROactive (PROspective PioglitAzone Clinical Trial In MacroVascular Events) study was a prospective, randomized, placebo-controlled outcomes trial. The study included 5,238 patients with type 2 diabetes and a history of macrovascular disease, who were force titrated up to 45 mg daily of either ACTOS or placebo. In this study, there was no difference in the number of macrovascular events between standard of care and ACTOS, and standard of care alone. Although there was no statistically significant difference between ACTOS and standard of care for the primary endpoint, there was no increase in mortality or total macrovascular events with ACTOS.

The ACTOS Prescribing Information was recently revised by the FDA to include this reassuring cardiovascular safety data making ACTOS the only TZD with safety data from a cardiovascular outcomes trial in its label.

About ACTOS

ACTOS works by directly targeting insulin resistance, a condition in which the body does not efficiently use the insulin it produces to control blood glucose levels. ACTOS is taken once daily as an adjunct to diet and exercise, and is approved for use for type 2 diabetes as monotherapy to lower blood glucose and in combination therapy with insulin, sulfonylureas or metformin.

Important Safety Information About ACTOS

The prescription medication ACTOS is used along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes. ACTOS is taken once daily either alone or in combination with insulin, sulfonylureas, or metformin.

ACTOS is not for everyone. Certain patients with heart failure should not start taking
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab
2. Largest Ever Study of Genetics Behind Common Diseases Published
3. A Just Published Book Promises To Guide Women Regarding Their Frequent UTI’
4. Findings on Dangerous Parasite, Toxoplasma Gondii Published
5. Siddha Medicine Texts to Be Published in English
6. Journal Recommends How To Improve The Performance Of Health Workers
7. Medical Journals should create awareness on Child survival
8. A journal’s report on stress, among pregnant wome
9. Canadian Medical Association Journals Editorial Mess Gets Murkier
10. Journalists Blamed For Bird Flu Spread Across Israel
11. Future of Canadian Medical Association Journal Threatened
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... locations will each receive $100,000 in funding to launch ... follow-up care for patients served by community health centers. ... Cancer Roundtable and is part of the group,s effort ... 50 and over receiving regular screening for colorectal cancer ... competitive process are: Port Royal, South Carolina; New Haven, ...
(Date:8/27/2014)... 27, 2014 Driven by the expanded ... expected to grow steadily during the next few years, ... 1.381 billion meters by end-2017. Tightness is an essential ... one of the most-used parts in an automobile. As ... at 995 million meters, up just under 15% y-o-y. ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Georgia ... has received a two-year, $600,000 grant from the ... Resources and Services Administration to support implementation of ... services for children and youth with autism spectrum ... worked with an Autism Advisory Council composed of ...
(Date:8/27/2014)... last things a parent wants to deal with, but ... a week old. , Skin that turns yellow can ... and isn,t adequately eliminating the chemical bilirubin. But that ... left untreated can harm a baby. , University of ... that checks for jaundice in newborns and can deliver ...
(Date:8/27/2014)... 2014) -- Extremely low levels of the compound in ... halt the progression of Alzheimer,s disease, a recent study ... , Findings from the experiments, using a cellular model ... Journal of Alzheimer,s Disease . , Researchers from ... low doses of THC reduce the production of amyloid ...
Breaking Medicine News(10 mins):Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 3Health News:Automobile Weatherstrip Sector in China Analysed in New SinoMarketInsight Research Study Published at MarketPublishers.com 2Health News:Automobile Weatherstrip Sector in China Analysed in New SinoMarketInsight Research Study Published at MarketPublishers.com 3Health News:Center for Leadership in Disability Awarded $600,000 Grant to Improve Services for Georgia’s Children and Youth with Autism 2Health News:New smartphone app can detect newborn jaundice in minutes 2Health News:New smartphone app can detect newborn jaundice in minutes 3Health News:Marijuana compound may offer treatment for Alzheimer's disease 2
... managed by a specialty pharmacy program were more compliant ... hospitalized for their disease than those who were not ... study completed by HealthCore, Inc. , HealthCore researcher Jingbo ... of Pharmacoeconomic and Outcomes Research 14th Annual International Meeting ...
... against Chronic Migraines from Post-Traumatic Stress DisorderNEW YORK, May ... is making its new migraine treatment available free to ... According to published reports, alarming numbers of service men ... are suffering from migraines related to post-traumatic stress disorder ...
... WASHINGTON, May 20 The Council for American ... appointment and confirmation of Margaret Hamburg, M.D., to ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO )"Commissioner Hamburg takes ... States faces unprecedented challenges in public health, and ...
... an economic environment in which all Americans are trying ... were prevented from filling critical prescriptions due to healthcare ... a solution. Medtipster ( www.medtipster.com ) has ... search engine and generic prescription drug price comparator. Now ...
... care for a loved can be a very complicated issue ... begin, let alone the right questions to ask when they ... consider it.The Heinz Family Philanthropies is adding a new series ... " 10 QUESTIONS TO ANSWER... "About Long-term Care. This ...
... the 80th anniversary of The Children,s Center of Wayne ... a Power of Possibilities Breakfast is being held on ... http://www.newscom.com/cgi-bin/prnh/20090423/CCWCLOGO ) Embarking on its ... of founder Senator James Couzens. His intention was ...
Cached Medicine News:Health News:MS patients more compliant with medications when managed by specialty pharmacy 2Health News:Clinical Topicals Makes Breakthrough Migraine Treatment Available Free to Soldiers 2Health News:Council for American Medical Innovation Applauds the Confirmation of Margaret Hamburg, M.D., to Lead U.S. Food and Drug Administration 2Health News:Medtipster, a Search Engine With a National Database of Generic Drugs on Discount Programs That Allows Visitors to Search by Zip Code, by Lowest Price, is Now Out of Beta 2Health News:Heinz Family Philanthropies (www.heinzfamily.org) Release Questions Families Should Ask About Long-Term Care - 10 Questions to Answer...(www.tenquestionstoanswer.org) 2Health News:Heinz Family Philanthropies (www.heinzfamily.org) Release Questions Families Should Ask About Long-Term Care - 10 Questions to Answer...(www.tenquestionstoanswer.org) 3Health News:80th Anniversary Power of Possibilities Breakfast Honors the Children's Center of Wayne County 2
(Date:8/27/2014)... , Aug. 27, 2014   Los Angeles orthodontics ... AcceleDent® Aura to patients who want to make their ... available at the OrthoSpaceship, all patients have a powerful ... This system can be used by most patients with ... of progress by using the AcceleDent® Aura system for ...
(Date:8/27/2014)... By now, if you haven,t heard about the ... planet. The awareness campaign has brought this devastating disease to ... over $88.5 Million (and counting) for ALS. Every day, more ... starting to as well. One such company, Acorn ... who actually works with ALS sufferers and helps to provide ...
(Date:8/27/2014)... York , August 27, 2014 ... United States  Laparoscopes Market Outlook to 2020. ... provides key market data on the United States ... of US dollars, volume (in units) and average prices ... Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), Robotic ...
Breaking Medicine Technology:Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5
... Del., Dec. 22, 2010 AstraZeneca ... notified Abbott that it will discontinue the development of CERTRIAD™ ... the treatment of mixed dyslipidemia. This means the co-development and ...   A Complete Response Letter (CRL) for the ...
... Dec. 22, 2010 The U.S. Food and Drug Administration ... anal cancer and associated precancerous lesions due to human ... people ages 9 through 26 years. (Logo: ... approved for the same age population for the prevention ...
Cached Medicine Technology:FDA: Gardasil Approved to Prevent Anal Cancer 2FDA: Gardasil Approved to Prevent Anal Cancer 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: